Dolby Laboratories, Inc. (DLB) Form 8-K — Jul 30, 2026
Dolby Laboratories reported financial results for its fiscal third quarter ended June 26, 2026, with total revenue decreasing to $305 million from $316 million in the prior-year quarter. GAAP net income fell to $29 million, or $0.30 per diluted share, compared to $46 million, or $0.48 per diluted share, in the same period last year, though non-GAAP EPS was $0.69. Despite the earnings decline, the Board of Directors approved a $350 million increase to the company's stock repurchase authorization, raising the total available for future buybacks to approximately $427 million.
Key figures
- Eps
- 0.30
- Revenue
- 305 million
- Guidance
- Total revenue for Q4 expected to be $362 million to $392 million; Full year revenue expected to be $1.41 billion to $1.44 billion
- Net Income
- 29 million
- Debt Amount
- 0
- Shares Repurchased
- 1.2 million
- Non Gaap EPS
- 0.69
- Dividend Per Share
- 0.36
- Quarterly Repurchase Spend
- 65 million
- Repurchase Authorization Increase
- 350 million
- Remaining Repurchase Authorization
- 427 million
Price after filing
Close on the filing date to close N calendar days later (from $52.51). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.